Seer Number of Employees 2020-2022 | SEER

Seer number of employees from 2020 to 2022. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Seer Annual Number of Employees
2021 118
2020 60
2019
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.539B $0.007B
Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $166.663B 10.14
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.600B 16.73
Biohaven Pharmaceutical Holding (BHVN) United States $10.272B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.442B 0.00
Arcus Biosciences (RCUS) United States $1.751B 44.38
Emergent Biosolutions (EBS) United States $1.534B 6.57
Myovant Sciences (MYOV) United Kingdom $1.224B 0.00
Zymeworks (ZYME) Canada $0.317B 0.00
Gelesis Holdings (GLS) United States $0.111B 0.00
Ambrx Biopharma (AMAM) United States $0.100B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
SQZ Biotechnologies (SQZ) United States $0.089B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00